Sudeep Pharma Q2 Results FY27: Net Profit Rises 10.75% to Rs 51.81 Cr, Revenue Rs 196.70 Cr

Sudeep Pharma Ltd (SUDEEPPHRM) announced Q2 Results FY27 on 28 October 2026, covering the company’s July to September quarter. The results date came with consolidated results showing revenue of Rs 196.70 Cr and net profit of Rs 51.81 Cr, and Sudeep Pharma Q2 Results FY27 compare both with the quarter a year before.

This results analysis from Univest looks at how revenue, Operating Profit and net profit moved across Sudeep Pharma Q2 Results, and then at the business drivers, outlook and risks. The Financial Highlights table opens the analysis, with the key takeaways and detailed commentary after it.

Click Here – Get Free Investment Predictions

Sudeep Pharma Q2 Results FY27: Financial Highlights

Source: company filing for Sudeep Pharma Q2 Results FY27, 28 October 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Sudeep Pharma Q2 Results: What Stands Out

• Revenue: Revenue grew 20.92% YoY to Rs 196.70 Cr from Rs 162.67 Cr in the year-ago quarter.
• Net profit: Net profit was Rs 51.81 Cr against Rs 46.78 Cr a year earlier, an increase of 10.75% YoY in Sudeep Pharma Q2 Results FY27.
• Operating Profit: Operating Profit reached Rs 73.24 Cr compared with Rs 55.46 Cr, a rise of 32.06% YoY.
• Net margin: Net profit margin narrowed to 26.3% from 28.8% in the comparison quarter, according to the disclosed figures.
• Next step: The performance analysis below places the revenue, Operating Profit and net profit lines next to each other.

Sudeep Pharma Q2 Results FY27: Performance Analysis

Revenue and profit both rose, though at different speeds. Sudeep Pharma recorded consolidated revenue of Rs 196.70 Cr, 20.92% above the Rs 162.67 Cr of the same quarter last year, while net profit of Rs 51.81 Cr was 10.75% above Rs 46.78 Cr. Net profit therefore grew at about half the pace of sales over the period.

Operating Profit gives a different reading in this results analysis. At Rs 73.24 Cr it was 32.06% higher than the Rs 55.46 Cr of the comparison quarter, a faster gain than revenue showed. The narrower growth in net profit, set against this stronger Operating Profit, is the main contrast in the quarterly results on the Consolidated basis, and the Financial Highlights table shows each line.

Readers following Sudeep Pharma Q2 Results will look for the next filings on the NSE and BSE to see how YoY growth develops across the three lines. The Univest Screener lets them compare these metrics with other listed companies, and the disclosed business factors come next. Each of the three lines carries its own YoY figure, so readers can see where growth was faster and where it was slower.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – Revenue grew 20.9% YoY to Rs 196.70 Cr in the latest quarter, the first disclosed factor and the base for the profit figures reported in Sudeep Pharma Q2 Results FY27.

Net Profit Gain – Net profit rose 10.8% YoY to Rs 51.81 Cr, the second disclosed factor, even though it grew more slowly than the sales line in the same quarterly results.

Return Ratios – Return on equity was 25.37% in FY26 and return on capital employed was 28.50% in FY26, the third disclosed factor, which show how much profit the company earned on shareholder funds and on the capital it employs over the full year.

FY27 Outlook After Sudeep Pharma Q2 Results

The quarter gives a reference for FY27, since revenue, Operating Profit and net profit all rose YoY. This results analysis does not project a full-year figure, because the remaining quarters of FY27 are yet to be declared.

After this results date, the next filings on the Univest app can be set against revenue of Rs 196.70 Cr and net profit of Rs 51.81 Cr. Before that, the risks listed with the consolidated results are worth reading, because they qualify the growth figures above and give a fuller view of the quarter.

Key Risks to Watch After Sudeep Pharma Q2 Results FY27

Narrower Net Margin

Net profit margin narrowed to 26.3% from 28.8% in the comparison quarter. Anyone reading Sudeep Pharma Q2 Results FY27 should weigh this beside the rise in net profit.

Lower Return on Equity

Return on equity declined to 25.37% in FY26 from 32.76% in FY25. The fall is part of the disclosed risk picture and is separate from the quarterly YoY growth.

Lower Return on Capital

Return on capital employed declined to 28.50% in FY26 from 35.83% in FY25, so both return ratios were lower for the full year than a year before, as the disclosed figures show.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Sudeep Pharma Q2 Results FY27 show consolidated revenue of Rs 196.70 Cr and net profit of Rs 51.81 Cr, both higher YoY. Taken together, the quarterly results describe growth in sales and profit, while Sudeep Pharma Q2 Results on a Consolidated basis also record a narrower net margin and lower return ratios as points to follow. Investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Sudeep Pharma Q2 Results FY27

What are Sudeep Pharma Q2 Results FY27?

Ans. Sudeep Pharma Q2 Results FY27 cover the July to September 2026 quarter, with consolidated revenue of Rs 196.70 Cr and net profit of Rs 51.81 Cr, as laid out in the Quick Answer at the top of this article.

When were Sudeep Pharma Q2 Results FY27 declared?

Ans. The results date was 28 October 2026, when Sudeep Pharma declared quarterly results for July to September 2026, so the Financial Highlights table draws on the figures from that filing.

What revenue did Sudeep Pharma report in the quarter?

Ans. Sudeep Pharma reported consolidated revenue of Rs 196.70 Cr, against Rs 162.67 Cr in the year-ago quarter, which is the revenue figure shown in the Financial Highlights table.

What net profit did Sudeep Pharma report in the quarter?

Ans. Net profit was Rs 51.81 Cr compared with Rs 46.78 Cr a year earlier, so the Performance Analysis section describes a 10.75% YoY increase in profit.

What was the YoY growth in revenue for Sudeep Pharma Q2 Results?

Ans. Revenue showed YoY growth of 20.92% in the quarter, moving from Rs 162.67 Cr to Rs 196.70 Cr, and the Key Takeaways section sets this next to the smaller profit increase.

Did net profit rise in Sudeep Pharma Q2 Results?

Ans. Yes, net profit rose to Rs 51.81 Cr from Rs 46.78 Cr, and the Performance Analysis section notes that this 10.75% YoY gain was smaller than the revenue growth of 20.92%.

What was the Operating Profit in Sudeep Pharma Q2 Results FY27?

Ans. Operating Profit was Rs 73.24 Cr against Rs 55.46 Cr a year earlier, an increase of 32.06% YoY, as the Key Takeaways section records for the quarter.

Are these consolidated results or standalone results?

Ans. These are consolidated results, so every revenue and profit figure in this article follows the Consolidated basis, as stated in the opening paragraphs and in the Quick Answer.

Which business factors shaped Sudeep Pharma Q2 Results FY27?

Ans. Revenue growth of 20.9% YoY, net profit growth of 10.8% YoY and return ratios of 25.37% and 28.50% in FY26 are the disclosed factors, covered in the Key Business Factors section.

What are the key risks after Sudeep Pharma Q2 Results FY27?

Ans. The disclosed risks are a net profit margin that narrowed to 26.3% from 28.8%, a lower return on equity and a lower return on capital employed, covered in the Key Risks section.

What is the outlook after Sudeep Pharma Q2 Results?

Ans. Prospects for the full year will depend on how revenue and net profit trend in the quarters still to come, which means the Outlook section ties this analysis to later filings.

Where can I see the full Sudeep Pharma Q2 Results FY27 data?

Ans. The complete figures appear in the Financial Highlights table above, and the Univest Screener lets readers compare revenue and net profit across listed companies, as the Performance Analysis section notes.